In Vitro Activity of Telavancin against Staphylococcus aureus Causing Pneumonia or Skin and Skin Structure Infections with Concomitant Bloodstream Infections in United States Hospitals (2012-2016)
In Vitro Activity of Telavancin against Staphylococcus aureus Causing Pneumonia or Skin and Skin Structure Infections with Concomitant Bloodstream Infections in United States Hospitals (2012-2016). Lead author: L Duncan, presented at ASM Microbe 2017, June 1-5, New Orleans, Louisiana, USA
# Sunday-141
